Johnny Huard

Aging · 2020

⊕ Preprint · CC-BY

ATM is a key driver of NF-κB-dependent DNA-damage-induced senescence, stem cell dysfunction and aging

▲ 114

Aging Cell · 2021

⊕ Open access · CC-BY

Novel small molecule inhibition of IKK/NF‐κB activation reduces markers of senescence and improves healthspan in mouse models of aging

▲ 82

Journal of Osteoporosis · 2023

⊕ Open access · CC-BY

The Senolytic Drug Fisetin Attenuates Bone Degeneration in the Zmpste24−/− Progeria Mouse Model

▲ 42

Cells · 2023

⊕ Open access · CC-BY

Therapeutic Perspectives for Inflammation and Senescence in Osteoarthritis Using Mesenchymal Stem Cells, Mesenchymal Stem Cell-Derived Extracellular Vesicles and Senolytic Agents

▲ 42

Cell Death and Disease · 2024

⊕ Open access · CC-BY

mtDNA release promotes cGAS-STING activation and accelerated aging of postmitotic muscle cells

▲ 37

Journal of Orthopaedic Research® · 2016

⊕ Open access · CC-BY

mTOR signaling plays a critical role in the defects observed in muscle-derived stem/progenitor cells isolated from a murine model of accelerated aging

▲ 34

Antioxidants · 2023

⊕ Open access · CC-BY

Effects of Fisetin Treatment on Cellular Senescence of Various Tissues and Organs of Old Sheep

▲ 25

Aging Cell · 2024

⊕ Open access · CC-BY

Clinical validation of <scp>C₁₂FDG</scp> as a marker associated with senescence and osteoarthritic phenotypes

▲ 18

Journal of Extracellular Vesicles · 2025

⊕ Open access · CC-BY

NK‐Cell‐Derived Extracellular Vesicles Engineered to Carry Senolytics Eliminate Chemotherapy‐Induced Senescent Osteosarcoma Cells

▲ 14

Preprints.org · 2023

⊕ Preprint · CC-BY

Effects of Fisetin Treatment on Cellular Senescence of the Brain and Other Multiple Organs of Old Sheep

▲ 10

Bioengineering · 2021

⊕ Open access · CC-BY

Rejuvenated Stem/Progenitor Cells for Cartilage Repair Using the Pluripotent Stem Cell Technology

▲ 6

bioRxiv (Cold Spring Harbor Laboratory) · 2022

⊕ Preprint · OA

Fisetin Attenuates Cellular Senescence Accumulation During Culture Expansion of Human Adipose-Derived Stem Cells

▲ 5

The FASEB Journal · 2020

◌ Citation only

The senolytic drug fisetin mitigates age‐related bone density loss in the progeroid mouse model <i>Zmpste24</i> ^{<i>−/−</i>}

▲ 3

Journal of Tissue Engineering and Regenerative Medicine · 2025

⊕ Open access · CC-BY

Combination Therapy of Losartan and Fisetin Reduces Senescence and Enhances Osteogenesis in Human Bone Marrow–Derived Mesenchymal Stem Cells

▲ 3